​
mobile-logo
 

Media

Cio Revuew

Innoplexus Brings Blockchain to Pharma

November 2, 2018 / Media
Global AI firm Innoplexus launched an innovative blockchain platform to dramatically raise the amount of data available for drug research...
handelsblatt

Founder fights cancer with artificial intelligence

October 23, 2018 / Media
Gunjan Bhardwaj helps pharmaceutical companies to find out more about diseases. By harnessing artificial intelligence, pharmaceutical companies are able to...
korea-conference

AI-based drug development to broaden gap between pharmaceuticals

October 15, 2018 / Media
Local pharmaceutical firms should brace for a new era where drugmakers take advantage of artificial intelligence (AI) to develop a...
gunjan-bilanz

Google for Pharma

October 11, 2018 / Media
Indian and Swabian   Together with friends from India, Gunjan Bhardwaj has successfully launched Innoplexus, a sophisticated ecosystem of continuous...
reflex-verlag

We want to democratize data

October 8, 2018 / Media
Dr. Gunjan Bhardwaj is the founder and CEO of Innoplexus AG. With the help of artificial intelligence, blockchain and big...
artificial-intelligence

How artificial intelligence impacts preventative care

September 26, 2018 / Media
With a dramatic rise in physician burnout and many physicians exiting the field prematurely, the health care industry is looking...
transparency-would-bolster

More transparency would bolster big pharma’s image

September 6, 2018 / Media
It’s no surprise that the public hates Big Pharma. They rank just under the government on most Americans’ despised institution list.
gdpr-and-data-privacy

Innoplexus is working on solutions in response to GDPR and other data privacy restrictions

August 29, 2018 / Media
Innoplexus is at the forefront of decision-making technology as the company works in data aggregation to provide to
solutions-developing-orphan

Why AI and blockchain are the solutions to developing orphan drug

August 20, 2018 / Media
We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on...
1 2 3 … 8

Global Press Contact

silke

Silke Otte

+49 160 47 200 17

Book a Free Consultation